Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
Titel:
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
Auteur:
Pignata, Sandro Lorusso, Domenica Joly, Florence Gallo, Ciro Colombo, Nicoletta Sessa, Cristiana Bamias, Aristotelis Salutari, Vanda Selle, Frédèric Frezzini, Simona De Giorgi, Ugo Pautier, Patricia Bologna, Alessandra Orditura, Michele Dubot, Coraline Gadducci, Angiolo Mammoliti, Serafina Ray-Coquard, Isabelle Zafarana, Elena Breda, Enrico Favier, Laure Ardizzoia, Antonio Cinieri, Saverio Largillier, Rémy Sambataro, Daniela Guardiola, Emmanuel Lauria, Rossella Pisano, Carmela Raspagliesi, Francesco Scambia, Giovanni Daniele, Gennaro Perrone, Francesco